Navigation Links
Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
Date:10/29/2009

com/">www.endo.com.

The following tables present Endo's unaudited Total Revenues for the three months ended September 30, 2009 and September 30, 2008:


                         Endo Pharmaceuticals Holdings Inc.
                              Total Revenues (unaudited)
                                  (in thousands)

                                   Three Months Ended
                                     September 30,

                                       2009             2008     Growth

     LIDODERM(R)                   $192,738         $194,138        (1%)
     OPANA(R) ER and OPANA(R)        58,894           41,496         42%
     PERCOCET(R)                     30,690           31,371        (2%)
     Voltaren(R) Gel                 19,584           10,299         90%
     FROVA(R)                        15,000           14,306          5%
     SUPPRELIN(R) LA                  8,092               --         NM
     VANTAS(R)                        6,491               --         NM
     Other Brands                     3,927            2,748         43%

           Total Brands            $335,416         $294,358         14%

           Total Generics           $22,928          $22,410          2%

           Total Royalty and Other                                   NM
            Revenue                  $2,683              $--

                 Total Revenues    $361,027         $316,768         14%



The following tables present Endo's unaudited Total Revenues for the nine months ended September 30, 2009 and September 30, 2008:


                        Endo Pharmaceuticals Holdings Inc.
                            Total Revenues (unaudited)
                                 (in thousands)

                                     Nine months Ended
                                       September 30,

                                         2009             2008     Growth

     LIDODERM(R)          
'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
2. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
4. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
5. DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
6. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
7. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
8. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
9. Bellicum Pharmaceuticals Announces $4.5 Million in New Funding
10. BioMarin Acquires Huxley Pharmaceuticals, Inc.
11. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015   Millar, Inc. , a leader ... the 2016 retirement of Craig Thummel , President/CEO ... years of service to the Company. The Company also ... members of the Executive Management team as his successors. ... , currently Director of Sales and Marketing, as President, ...
(Date:6/30/2015)... VALLEY, Pa. , June 30, 2015 /PRNewswire/ ... and delivering innovative solutions for medical and surgical ... is guaranteeing next-day replacements for surgical equipment at ... product manufacturer to offer this type of guarantee. ... Olympus Full Service Agreement earlier this year. ...
(Date:6/30/2015)... Calif. , June 30, 2015  Ardelyx, Inc. ... on cardio-renal, gastrointestinal and metabolic diseases, today announced that ... July 14, 2015, from 8:00 a.m.- 1:00 pm EDT ... The Ardelyx senior management team will present ... lead compound, tenapanor, which has completed Phase 2b clinical ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2
... The U.S. Food and Drug Administration is requiring ... on their labels about the risk of a ... systemic fibrosis (NSF), if the drug is administered ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:   ...
... (Nasdaq: MSON ), a developer of ... which worldwide is used for acute health conditions, ... distribution agreement with Dismeval, s.l.,  based in Valencia, ... Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone ...
Cached Medicine Technology:FDA: New Warnings Required on Use of Gadolinium-Based Contrast Agents 2Misonix Announces New Distribution Agreement For Spain 2Misonix Announces New Distribution Agreement For Spain 3
(Date:6/30/2015)... ... June 30, 2015 , ... CCAR is pleased to ... Community Centers in Hartford, Willimantic and Bridgeport. This month, staff member Jim Higgins ... Coach Manager. He is excited to take on this role of organizing peer ...
(Date:6/30/2015)... ... June 30, 2015 , ... America’s oldest cancer ... access to cancer prevention, screening and care for the people of Nigeria. Roswell ... that will see Roswell Park faculty providing clinical consultations to assist LCC oncologists, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Independence Day weekend is more than just fireworks ... kick off of July as National Hot Dog Month. Americans are expected to eat ... time of the year and enough to stretch from Washington D.C. to Los Angeles ...
(Date:6/30/2015)... ... ... After more than five years of research and development that includes ... specifically formulated for the unique skin of all people of color — is now ... time to help protect the skin of all people of color this July Fourth ...
(Date:6/30/2015)... ... June 30, 2015 , ... LifeAID Beverage Company ... two leading organizations dedicated to raising worldwide awareness of the burgeoning “adaptive” movement, ... is now the official charity of FitAID. I AM ADAPTIVE is a non-profit ...
Breaking Medicine News(10 mins):Health News:The Connecticut Community for Addiction Recovery takes Recovery Coaching to a new level 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 4Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 5Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2Health News:GlobalSun – The First Sunscreen Developed for All People of Color – Hits The Market 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3
... Noted For His Discoveries About Attention And ... April 16 NeuroFocus, the world leader ... the application of brainwave-based measurements for market ... been named a Partner in the company,s ...
... Abbott/Eisai,s Humira Will Earn Decision Resources, Clinical Gold ... to a New Report from Decision ResourcesWALTHAM, Mass., ... world,s leading research and advisory firms for pharmaceutical ... a therapy,s effect on induction of remission as ...
... Next Generation Network magazine has named Zultys as a recipient of the ... , ... Sunnyvale, CA (PRWEB) April 15, 2009 -- Zultys Inc. ... Zultys as a recipient of the First Annual NGN Leadership Award for ...
... 16 WM Healthcare Solutions, Inc. (WMHS), a ... it has purchased substantially all of the assets ... provides pharmaceutical waste management consulting services to the ... and other custom consulting services, in addition to ...
... Workforce Prescriptions ("WRX") announced on Friday the launch of a no-cost online tool developed ... , , Overtime utilization ... Other "Premium Pay" utilization , Excessive ... Process labor waste , Productivity labor waste , ...
... Science adds Sage Intergy EHR as part of its strategy to lead ... 16 Cardiac Science Corporation (Nasdaq: CSCX ), a global ... cardiac stress test , cardiac rehab ... and HIS systems, announced today that it completed certification for its ...
Cached Medicine News:Health News:NeuroFocus Appoints Dr. Michael Smith as Partner in Consulting Practice 2Health News:For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission 2Health News:For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission 3Health News:Zultys Inc. Receives 2009 NGN Leadership Award from NGN Magazine 2Health News:Zultys Inc. Receives 2009 NGN Leadership Award from NGN Magazine 3Health News:Zultys Inc. Receives 2009 NGN Leadership Award from NGN Magazine 4Health News:Waste Management Subsidiary Acquires PharmEcology(R) Associates, LLC 2Health News:WRX Launches Hospital Labor Waste Calculator 2Health News:WRX Launches Hospital Labor Waste Calculator 3Health News:Cardiac Science Connects With EMR Partner Sage 2Health News:Cardiac Science Connects With EMR Partner Sage 3Health News:Cardiac Science Connects With EMR Partner Sage 4Health News:Cardiac Science Connects With EMR Partner Sage 5
... If you prefer a standard ... the Volk Iridectomy Lens. Its ... view you're used to but ... Volk's exclusive Double Aspheric design ...
... 2.2 offers extremely high resolution treatment capability ... an exceptionally wide 78° field of view. ... critical evaluation of the optic nerve head ... of the macula and disc. Redesigned to ...
... for focal laser therapy and mid-to-far peripheral ... a realistic contour of the retinal concavity, ... entire posterior pole extending to the equator. ... dynamic movement on the globe, therefore increasing ...
... The Digital 1.0x Imaging Lens is optimized ... reduce glare and reflections during general diagnosis and ... view of the posterior pole and a sharper ... Digital 1.0 X Imaging Lens is also ideal ...
Medicine Products: